Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bleb Vascularity Change After Subconjunctival Injection of Bevacizumab

NCT00815594 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT00815594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00815594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bleb Vascularity Change After Subconjunctival Injection of Bevacizumab
Lead sponsor
Capital Medical University
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2008
Completion date
May 31, 2009
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleb vascularity, conjunctival scarring